Y0001637

左卡巴斯汀

European Pharmacopoeia (EP) Reference Standard

• 别名: 左卡巴斯汀 盐酸盐, R50547, [3S-[1（顺式），3α，4β]]-1-[4-氰基-4-（4-氟苯基）环己基]-3-甲基-4-苯基-4-哌啶羧酸, 左旋多巴, 立复汀
• 经验公式（希尔记法）: C₂₆H₂₉N₂O₂F·HCl
• CAS号: 79547-78-7
• 分子量: 456.98
• MDL號碼: MFCD07787408
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329831521
• NACRES: NA.24

属性

• 等級: pharmaceutical primary standard
• API 家族: levocabastine
• 製造商／商標名: EDQM
• 應用: pharmaceutical (small molecule)
• 格式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: Cl[H].C[C@@H]1CN(CC[C@]1(C(O)=O)c2ccccc2)[C@@H]3CC[C@@](CC3)(C#N)c4ccc(F)cc4
• InChI: 1S/C26H29FN2O2.ClH/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20;/h2-10,19,23H,11-17H2,1H3,(H,30,31);1H/t19-,23-,25-,26-;/m1./s1
• InChI 密鑰: OICFWWJHIMKBCD-VALQNVSPSA-N
• 基因資訊: human ... HRH1(3269)

说明

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Levocabastine for system suitability 2 EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

生化／生理作用

非肽类组胺H₁ 受体拮抗剂；神经降压素NTS₂受体配体。

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H315,H319,H335
• 防範說明: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• 危險分類: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• 標靶器官: Respiratory system
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3